Join our flagship ecosystem-building event, convening investors, industry representatives, entrepreneurs and academic innovators/spinouts.
The 2026 Weill Cornell Medicine BioInnovate Conference brings together academic founders with investors, industry representatives, entrepreneurs and ecosystem partners with the expressed goal to connect and collaborate. The conference is a rare opportunity to meet a diverse group of life science inventors and spinout companies across therapeutics, device, digital health and diagnostic sectors. All Weill Cornell Medicine-affiliated inventors are encouraged to participate. In addition, select startup companies from the Upper East Side ecosystem as well as startups where faculty serve as CMOs and scientific advisors are also in attendance.
Over the years, this event has been a proven catalyst for direct investment from early-stage investors, co-development relationships with industry, and introductions to experienced management teams.